A RCT ON THE EFFICACY OF NIMBADI YONI VARTI ON ABNORMAL VAGINAL DISCHARGE IN REPRODUCTIVE AGED WOMEN
DOI:
https://doi.org/10.70066/jahm.v2i6.182Keywords:
Bacterial vaginitis, ,Abnormal Vaginal Discharge, vaginal suppository, Shveta PradaraAbstract
Background: Shwetapradara (Vaginal discharge), in female is a most common complaint encountered everyday both by
gynaecologists and general practitioners. Objectives: The present study was designed to evaluate the comparative efficacy
of the “nimbadi yoni varti” with that of clingen vaginal suppository. Methods: Total 104 diagnosed Patients of abnormal
vaginal discharge confirmed by vaginal smear & gram staining were selected for randomized control trial, out of them 50
patients each were divided in two groups (excluding drop outs) named Group A & group B. Group A received Nimbadi
yoni varti as trial drug & Group B received Clingen vaginal suppository as standard control drug. Results: Complete
remission was found in 4% patients, 78% were found markedly improved and 18% patients were moderately improved in
trial group while in Clingen vaginal suppository group, complete remission was found only in 2% patients, 66% were
observed with marked improvement, 32% moderately improved & no any patients remain unchanged or mild improved.
Conclusion: It was observed that Nimbadi Yoni Varti gave better results in both subjective and objective variables in
comparison with the control group. Therefore, Nimbadi Yoni varti has proved to be an effective therapy in the management
of Shwetapradara (vaginal discharge), and will also help in deriving new conclusion and axioms.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Poonam Sharma
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
